share_log

Kaival Brands Innovations | 10-Q: Q2 2024 Earnings Report

Kaival Brands Innovations | 10-Q: Q2 2024 Earnings Report

Kaival Brands Innovations | 10-Q：2024财年二季报
美股SEC公告 ·  2024/06/19 05:20

Moomoo AI 已提取核心信息

Kaival Brands Innovations Group reported Q2 2024 revenue of $2.2 million, down from $3.0 million in Q2 2023, with a net loss of $1.5 million compared to $4.0 million loss year-over-year. The company achieved a gross profit of $0.5 million or 22.4% of revenue, improving from a gross loss in the prior year period, driven by fewer customer credits and decreased cost of revenue.Operating expenses decreased significantly to $1.8 million from $3.8 million in Q2 2023, primarily due to reduced advertising costs of $0.3 million and lower stock option expenses. The company maintained $488,083 in cash as of April 30, 2024, though management noted substantial doubt about its ability to continue as a going concern due to working capital deficits and regulatory uncertainties.The company faces ongoing challenges from FDA's January 2024 marketing denial order regarding its Classic BIDI Stick product and needs additional funding to support operations. Management is pursuing increased marketing efforts and sales growth while exploring strategic options, including potential licensing opportunities from its recently acquired GoFire intellectual property assets.
Kaival Brands Innovations Group reported Q2 2024 revenue of $2.2 million, down from $3.0 million in Q2 2023, with a net loss of $1.5 million compared to $4.0 million loss year-over-year. The company achieved a gross profit of $0.5 million or 22.4% of revenue, improving from a gross loss in the prior year period, driven by fewer customer credits and decreased cost of revenue.Operating expenses decreased significantly to $1.8 million from $3.8 million in Q2 2023, primarily due to reduced advertising costs of $0.3 million and lower stock option expenses. The company maintained $488,083 in cash as of April 30, 2024, though management noted substantial doubt about its ability to continue as a going concern due to working capital deficits and regulatory uncertainties.The company faces ongoing challenges from FDA's January 2024 marketing denial order regarding its Classic BIDI Stick product and needs additional funding to support operations. Management is pursuing increased marketing efforts and sales growth while exploring strategic options, including potential licensing opportunities from its recently acquired GoFire intellectual property assets.
Kaival Brands创新集团（Kaival Brands）报告了截至2024年4月30日的季度财务业绩，揭示净营业收入为2,226,314美元，较去年同期的3,020,302美元有所下降。公司的营业成本为1,726,658美元，导致毛利润为499,656美元。然而，营业费用高达1,755,368美元，导致本季度净亏损1,527,178美元。普通股每股亏损为0.56美元。公司资产负债表显示，流动资产为1,901,653美元，总资产为13,889,516美元。当前负债报告为3,258,050美元，总负债为4,025,499美元。公司股东权益为9,864,017美元。Kaival Brands...展开全部
Kaival Brands创新集团（Kaival Brands）报告了截至2024年4月30日的季度财务业绩，揭示净营业收入为2,226,314美元，较去年同期的3,020,302美元有所下降。公司的营业成本为1,726,658美元，导致毛利润为499,656美元。然而，营业费用高达1,755,368美元，导致本季度净亏损1,527,178美元。普通股每股亏损为0.56美元。公司资产负债表显示，流动资产为1,901,653美元，总资产为13,889,516美元。当前负债报告为3,258,050美元，总负债为4,025,499美元。公司股东权益为9,864,017美元。Kaival Brands的业务发展包括与Bidi Vapor，LLC签订了尼古丁电子递送系统（ENDS）的独家分销协议，以及成立了用于产品开发和国际许可协议的子公司。公司未来的计划包括持续努力通过增加营销和销售倡议来增加收入并实现盈利能力。财务报告还强调了FDA的监管决定对公司产品提供的影响，以及在经典BIDI® Stick的营销否决令上正在进行的第11巡回上诉法院的诉讼程序的影响。

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    22nd Century
    XXII
    -- 1.5076
    菲利普莫里斯
    PM
    -- 155.310
    英美烟草
    BTI
    -- 40.515
    Turning Point Brands
    TPB
    -- 59.045
    奥驰亚
    MO
    -- 58.315
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日